Obstructive sleep disordered breathing in children - an important problem in the light of current European guidelines

Area of Science:

• Pediatric Pulmonology
• Sleep Medicine
• Clinical Guidelines

Background:

• Obstructive sleep-disordered breathing (SDB) is prevalent in children and can lead to severe cardiovascular, neurological, and growth complications.
• Undiagnosed and untreated SDB poses a significant threat to a child's developing health.
• Previous guidelines from the American Academy of Pediatrics (2012) focused on specific populations, highlighting the need for broader recommendations.

Purpose of the Study:

• To present the 2015 European Respiratory Society Task Force guidelines for diagnosing and treating SDB in children and adolescents (ages 2-18).
• To systematize the recognition, diagnosis, and treatment of SDB, addressing its causes and complications.
• To provide a comprehensive overview of potential therapeutic actions for SDB in pediatric populations.

Main Methods:

• The guidelines synthesize scientific data from 362 publications.
• Evidence quality was assessed using the American Academy of Neurology (ANN) classification (Classes I-IV).
• A structured "seven steps" approach was developed for diagnosis and treatment planning.

Main Results:

• The guidelines emphasize the limited availability of high-quality evidence, such as prospective and randomized controlled trials.
• They offer a broad spectrum of diagnostic and therapeutic strategies.
• The document aims to improve the recognition and management of SDB across all levels of medical care.

Conclusions:

• The 2015 European guidelines provide a comprehensive framework for pediatric SDB management.
• Improved recognition and systematic diagnosis/treatment are crucial for mitigating SDB's serious health consequences in children.
• Further high-quality research is needed to strengthen the evidence base for SDB interventions.